Indomethacin amides as a novel molecular scaffold for targeting Trypanosoma cruzi sterol 14alpha-demethylase.
about
CYP51 structures and structure-based development of novel, pathogen-specific inhibitory scaffoldsCrystal structures of Trypanosoma brucei sterol 14alpha-demethylase and implications for selective treatment of human infectionsBioactive lipids in Trypanosoma cruzi infectionStructural Insights into Inhibition of Sterol 14 -Demethylase in the Human Pathogen Trypanosoma cruziComplexes of Trypanosoma cruzi Sterol 14 -Demethylase (CYP51) with Two Pyridine-based Drug Candidates for Chagas Disease: STRUCTURAL BASIS FOR PATHOGEN SELECTIVITYStructural Basis for Rational Design of Inhibitors Targeting Trypanosoma cruzi Sterol 14α-Demethylase: Two Regions of the Enzyme Molecule Potentiate Its InhibitionTrypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental ModelSterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasisAspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas diseaseAzole binding properties of Candida albicans sterol 14-alpha demethylase (CaCYP51).Resistance to antifungals that target CYP51.Drug strategies targeting CYP51 in neglected tropical diseasesTargeting Trypanosoma cruzi sterol 14α-demethylase (CYP51)Azole affinity of sterol 14α-demethylase (CYP51) enzymes from Candida albicans and Homo sapiens.Design or screening of drugs for the treatment of Chagas disease: what shows the most promise?Trypanocidal drugs: mechanisms, resistance and new targets.Podophyllotoxin analogues active versus Trypanosoma brucei.Recent Developments in Sterol 14-demethylase Inhibitors for Chagas Disease.
P2860
Q24605691-0EF10E7F-EA8A-4036-B03C-5104AC545EE4Q24648110-57472849-72C7-4833-9B79-2703F5011237Q26866224-013ED616-40AD-4227-8E86-8D3FA8D2FCFDQ27662136-71C727AA-07E3-406D-B719-94273F044F2EQ27679983-1EB3AE11-C383-41D0-91B1-B8C6EE0F3796Q27684715-D01871AE-D453-4EB0-884E-3D72B0FE455BQ28553573-2E94E797-9E6D-4D0E-B188-5418BFAC1F94Q28727454-2F68373D-0D31-4FE3-B3D0-6B01534DE842Q33828299-0897A940-08A9-451E-895E-0F2162D3C20CQ34150915-1FB7B653-221B-4DDB-B412-21AE35022D06Q34276700-BFCBD2CA-37BD-44E2-B03A-DBABA60D96D1Q34622554-7E764986-EEE5-40E4-9745-4AC943B56953Q36368984-97DFDBB0-0250-424E-B934-66196D3DE758Q36667070-38AEBC4C-3F2E-4649-AD14-A0D29A565BD0Q37401820-D97B7FE1-E80B-4994-9540-D52733202AE8Q37623081-D3333911-FC91-4889-B162-2B74C23946B9Q39744198-1E793A56-2554-426C-8690-DBE2D5C43D88Q41955446-89F68356-2BCD-4E9A-AAFB-EB395470CA24
P2860
Indomethacin amides as a novel molecular scaffold for targeting Trypanosoma cruzi sterol 14alpha-demethylase.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Indomethacin amides as a novel ...... zi sterol 14alpha-demethylase.
@en
Indomethacin amides as a novel ...... zi sterol 14alpha-demethylase.
@nl
type
label
Indomethacin amides as a novel ...... zi sterol 14alpha-demethylase.
@en
Indomethacin amides as a novel ...... zi sterol 14alpha-demethylase.
@nl
prefLabel
Indomethacin amides as a novel ...... zi sterol 14alpha-demethylase.
@en
Indomethacin amides as a novel ...... zi sterol 14alpha-demethylase.
@nl
P2093
P2860
P356
P1476
Indomethacin amides as a novel ...... zi sterol 14alpha-demethylase.
@en
P2093
Fernando Villalta
Galina I Lepesheva
Jens P von Kries
Lawrence J Marnett
Mary E Konkle
Md Jashim Uddin
Michael R Waterman
Richard M Caprioli
Tatiana Y Hargrove
W David Nes
P2860
P304
P356
10.1021/JM801643B
P407
P577
2009-05-01T00:00:00Z